Nonprofit

Title Due Date Maximum Award Amount Sort descending Description
Revolving Fund Program Varies

This program helps qualified non-profits create a revolving loan fund (RLF) that can provided financing for the extension and improvement of water and waste disposal systems in rural areas.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=333930
Community Air Protection Funds No Due Date Given Varies

Community Air Protection funds allow for immediate actions to improve the air quality of the most impacted communities across the state, while the other aspects of AB 617 are developed and implemented. Partnering with communities is essential to the success of these incentives, and both the California Air Resources Board (CARB) and air districts are looking to local community members and groups to help identify funding priorities

https://ww3.arb.ca.gov/msprog/cap/capfunds.htm
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) Varies

The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country. This FOA can support training for conducting research in a broad range of HIV research areas across HIV prevention, treatment, care, and quality of life continuum. This includes basic, epidemiologic, clinical, behavioral and social sciences, community-based, implementation, operations, health services, and health systems research. Cross-disciplinary research as well as HIV associated comorbidities and coinfections affecting the HIV epidemic will be supported under this FOA. An application should focus the proposed training program to strengthen research capacity in a defined high priority HIV scientific area aligned with NIH HIV/AIDS research priorities (NOT-OD-20-018) at a specific LMIC institution and collaborating LMIC partner institutions.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=339720
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Varies

This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists.The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investigators. These non-tenure track scientists, such as researchers within a research program, are vital to sustaining the biomedical research enterprise. It is anticipated that only exceptional scientists who want to pursue research within the context of an existing NCI-funded cancer research program, but not serve as independent investigators, will be competitive for this award.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=340731
Alternative TV Rating measurement system in Moldova Varies

The U.S. Embassy invites interested organizations to submit applications for projects that would provide reliable, statistically valid television ratings measurement in Moldova. This program has the goal of establishing an independent trusted provider of unbiased (open) data on TV audiences in Moldova to be used by advertisers, media outlets and other stakeholders. This funding opportunity is authorized by the Foreign Assistance Act of 1961. Program Objectives: Reliable and trustworthy ratings data are essential for a functioning media market. This project seeks a partner who has a research-based, creative proposal to collect and publish such data for Moldova. Applicants are encouraged to think broadly about the problem and propose solutions that will result in ratings data that reflect reality and can be proven to be accurate. Such a solution could include elements as laid out below: · Establishing a consortium of reputable organizations in Moldova to lead the process to create an alternative measurement system. · Consulting with Moldovan TV stations, media organizations, and advertising agencies during the design of the new rating system · Negotiating access to audience data with major Internet Service Providers (ISPs) whose services include access to TV as well as others who may have audience data. · Providing expert analysis of the data collected, including through the use of outside, independent experts. · Providing free access to ratings and independent data analysis. · Promoting the new service among stakeholders (advertisers, media outlets, business community). Applicants may also provide an adjusted plan or use their own vision on tackling the issue.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=343222
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) Varies

The purpose of the NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees to launch competitive, independent research careers. Researchers in the scientific areas of data science and cancer control science are especially encouraged to apply. This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary clinical trial, as part of their research and career development. Those not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion FOA (RFA-CA-22-035). This Funding Opportunity Announcement is for basic science experimental studies involving humans, referred to in NOT-OD-18-212 as prospective basic science studies involving human participants. These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should be submitted under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena

https://www.grants.gov/web/grants/view-opportunity.html?oppId=343568
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Research Short Course (R25 Independent Clinical Trial Not Allowed) Varies

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome (DS). As part of the INCLUDE Project, NIH is interested in expanding and diversifying the skilled DS clinical research workforce. The intent of this Funding Opportunity Announcement (FOA) is to encourage applications that develop creative and innovative short courses to train the next generation of DS researchers in state-of-the-art clinical research skills that will improve the understanding of the co-occurring clinical features in DS and support development of new treatments for health conditions experienced by those with DS.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=343901
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Varies

The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI U54 Resource-Related Research Projects proposing to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities.As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=344754
HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (Independent Basic Experimental Studies with Humans Required) Varies

The purpose of the NIH HEAL InitiativeSM Pathway to Independence Award (K99/R00) program is to support a cohort of new and talented independent investigators conducting Pain and/or SUD research, in order to increase the independent investigator workforce in research areas supported by the NIH HEAL InitiativeSM. This program is designed to facilitate a timely transition of eligible outstanding postdoctoral researchers from their mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. The program will provide independent NIH research support during this transition to help awardees establish independent research programs in areas supported by the NIH HEAL InitiativeSM.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=344927
Translational Centers for Microphysiological Systems (TraCe MPS) (U2C Clinical Trials Not Allowed) Varies

The purpose of this funding opportunity announcement (FOA) is to establish Centers to support research that will accelerate the translational use of Microphysiological Systems (MPS) in drug development through regulatory acceptance and adoption for industrial use, by establishing MPS that are fit-for-purpose for industry needs and have specific defined contexts of use (CoUs) and will be developed with consideration of applicable expectations to achieve regulatory approval. For this FOA, the term drugs refers to both human pharmacological and biological products unless otherwise specified. These Centers will further the development of MPS as drug development tools (DDTs) that, once qualified, will be made publicly and commercially available to fill unmet needs in drug development.

https://www.grants.gov/web/grants/view-opportunity.html?oppId=345135